Inovio Pharmaceuticals Inc (NASDAQ:INO) price on Friday, June 13, fall -3.85% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.00.
A look at the stock’s price movement, the close in the last trading session was $2.08. Turning to its 52-week performance, $12.33 and $1.42 were the 52-week high and 52-week low respectively. Overall, INO moved 6.38% over the past month.
Inovio Pharmaceuticals Inc’s market cap currently stands at around $73.35 million, with investors looking forward to this quarter’s earnings report slated for in July.
The average forecast suggests down to a -90.08% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 109k, representing a -49.94% decline on that reported in the last financial year.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 2 recommend INO as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
INO’s current price about -4.31% and 5.00% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 47.44, while 7-day volatility ratio is 3.11% and 4.12% in the 30-day chart. Further, Inovio Pharmaceuticals Inc (INO) has a beta value of 1.32, and an average true range (ATR) of 0.14. Analysts have given the company’s stock an average 52-week price target of $20, forecast between a low of $8 and high of $40. Looking at the price targets, the low is -300.0% off current price level while to achieve the yearly target high, price needs to move -1900.0%. Nonetheless, investors will most likely welcome a -900.0% jump to $20 which is the analysts’ median price.
If we refocus on Inovio Pharmaceuticals Inc (NASDAQ:INO), historical trading data shows that trading volumes averaged 669.09K over the past 3 months. The company’s latest data on shares outstanding shows there are 36.67 million shares.
The 0.79% of Inovio Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 37.18% of the company’s shares. Current price change has pushed the stock 9.29% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the INO stock continues to rise going into the next quarter.
